| Literature DB >> 32270954 |
Mario Augusto Cray da Costa1,2, André Luís Betero3, Jefferson Okamoto3, Marcelo Schafranski1, Elise Souza Dos Reis1, Ricardo Zanetti Gomes1.
Abstract
OBJECTIVE: To compare two groups of patients - the coronary endarterectomy group, with patients undergoing coronary artery bypass grafting (CABG) with coronary endarterectomy (CE), and the control group, with patients undergoing CABG without CE. We analyzed the rate of major outcomes (perioperative acute myocardial infarction [AMI], stroke, and mortality) and minor outcomes (time of cardiopulmonary bypass [CPB], time of aortic clamp, and postoperative length of hospital stay). We also determined the rates of early graft patency in patients undergoing CE.Entities:
Keywords: Cardiopulmonary Bypass; Coronary Artery Bypass; Endarterectomy; Length of Stay; Morbity; Myocardial Infarctation; Stroke
Mesh:
Year: 2020 PMID: 32270954 PMCID: PMC7089746 DOI: 10.21470/1678-9741-2018-0402
Source DB: PubMed Journal: Braz J Cardiovasc Surg ISSN: 0102-7638
Patients’ preoperative characteristics.
| CEG (n=25) | CG (n=221) | |||
|---|---|---|---|---|
| Male | 19 (76%) | 149 (74.1%) | 10.000 | |
| Age, years (median) | 60 | 64 | 0.1351 | |
| DM | 13 (52%) | 55 (32.7%) | 0.0734 | |
| Use of insulin | 5 (20%) | 17 (10.1%) | 0.1730 | |
| Creatinine clearance | > 85 ml/min | 8 (40%) | 79 (48.5%) | |
| 50-85 ml/min | 11 (55%) | 77 (47.2%) | 0.5437 | |
| < 50 ml/min | 1 (5%) | 6 (3.7%) | ||
| In dialysis | 0 (0.0%) | 1 (0.6%) | ||
| NYHA Class | I | 4 (20%) | 20 (12.3%) | |
| II | 8 (40%) | 52 (31.9%) | 0.4197 | |
| III | 8 (40%) | 80 (49.1%) | ||
| IV | 0 (0.0%) | 11 (6.7%) | ||
| Ejection fraction | > 50% | 22 (88%) | 171 (85.1%) | |
| 31-50% | 2 (8%) | 21 (10.4%) | 0.7446 | |
| 21-30% | 1 (4%) | 9 (4.5%) | ||
| ≤ 20 | 0 (0.0%) | 0 (0.0%) | ||
| Angina class IV (CCS) | 10 (40%) | 81 (40.3%) | 10.000 | |
| EuroSCORE II (median) | 16.300 | 20.300 | 0.6745 | |
CCS=Canadian Cardiovascular Society; CEG=coronary endarterectomy group; CG=control group; DM=diabetes mellitus; EuroSCORE=European System for Cardiac Operative Risk Evaluation; NYHA=New York Heart Association
Patients’ perioperative characteristics.
| CEG (n=25) | CG (n=221) | ||
|---|---|---|---|
| Urgency | 4 (16.0%) | 51 (25.4%) | 0.4580 |
| Aortic clamp time (mean) | 65.6 min | 51.5 min | 0.0004 |
| CPB time (median) | 95.0 min | 73.0 min | 0.0030 |
| Grafts | 2.92 (± 1.41) | 3.01 (± 0.70) | 0.7160 |
| Postoperative AMI | 1 (4.0%) | 2 (1.0%) | 0.2976 |
| Stroke | 1 (4.0%) | 2 (1.0%) | 0.2976 |
| Mean hospitalization time after surgery (days) | 6 | 6 | 0.8139 |
| Death | 2 (8%) | 23 (11.4%) | 10.000 |
AMI=acute myocardial infarction; CEG=coronary endarterectomy group; CG=control group; CPB=cardiopulmonary bypass
Frequency of vessels undergoing endarterectomy.
| Coronary artery | N | % |
|---|---|---|
| RCA | 6 | 22.22 |
| LAD | 13 | 48.15 |
| DGB | 3 | 11.11 |
| DGsB | 1 | 3.70 |
| PDA | 2 | 7.41 |
| MGB | 2 | 7.41 |
| Total | 27 | 100 |
|
|
| |
| One vessel | 23 | 92.0 |
| Two vessels | 2 | 8.0 |
| Total | 25 | 100 |
DGB=diagonal branch; DGsB=diagonalis branch; LAD=left anterior descending; MGB=marginal branch; PDA=posterior descending artery; RCA=right coronary artery
Graft patency in the arteries subjected to endarterectomy (N=19).
| Patency rates/vase | LAD, N (%) | DGB | MGB | RCA | PDA | Total |
|---|---|---|---|---|---|---|
| No injury | 1 (16.7%) | 0 (0%) | 1 (50%) | 0 (0%) | 1 (50.0%) | 5 (26.3) |
| ≤ 50% lesion | 2 (33.3%) | 2 (100%) | 1 (50%) | 2 (28.6%) | 0 (0%) | 7 (36.8) |
| > 50% lesion | 3 (50.0%) | 0 (0%) | 0 (0%) | 2 (28.6%) | 0 (0%) | 3 (15.8) |
| Occlusion | 0 (0%) | 0 (0%) | 0 (0%) | 3 (42.8%) | 1 (50%) | 4 (21.1) |
| Total | 6 (31.6%) | 2 (10.5%) | 2 (10.5%) | 7 (36.8%) | 2 (10.5%) | 19 (100%) |
DGB=diagonal branch; LAD=left anterior descending; MGB=marginal branch; PDA=posterior descending artery; RCA=right coronary artery
Comparison between graft patency in the arteries subjected to endarterectomy (N=19) by territory.
| Territory/patency rates | Pervious | Occluded | |
|---|---|---|---|
| Left coronary | 10 (100%) | 0 (0.00%) | 0.0325 |
| Right coronary | 5 (33.33%) | 4 (66.67%) | |
| Total | 15 (78.95%) | 4 (21.05%) |
| Abbreviations, acronyms & symbols | ||||
|---|---|---|---|---|
| AMI | = Acute myocardial infarction | DM | = Diabetes mellitus | |
| CABG | = Coronary artery bypass grafting | EuroSCORE | = European System for Cardiac Operative Risk Evaluation | |
| CAD | = Coronary artery disease | LAD | = Left anterior descending | |
| CCS | = Canadian Cardiovascular Society | LITA | = Left internal thoracic artery | |
| CE | = Coronary endarterectomy | LV | = Left ventricle | |
| CEG | = Coronary endarterectomy group | MGB | = Marginal branch | |
| CG | = Control group | NYHA | = New York Heart Association | |
| CPB | = Cardiopulmonary bypass | PDA | = Posterior descending artery | |
| DAPT | = Dual antiplatelet therapy | RCA | = Right coronary artery | |
| DGB | = Diagonal branch | |||
| DGsB | = Diagonalis branch | |||
| Authors’ roles & responsibilities | |
|---|---|
| MACC | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved; final approval of the version to be published |
| ALB | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; final approval of the version to be published |
| JO | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; final approval of the version to be published |
| MS | Drafting the work or revising it critically for important intellectual content; agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved; final approval of the version to be published |
| ESR | Drafting the work or revising it critically for important intellectual content; agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved; final approval of the version to be published |
| RZG | Drafting the work or revising it critically for important intellectual content; agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved; final approval of the version to be published |